Ulisse Biomed S.p.A.

    Ulisse Biomed S.p.A.

    MMIL:UBM
    - -
    EUR
    - -
    - -
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    2024 Y
    Revenue per Share
    - -
    - -
    0.07
    0.03
    - -
    0.01
    0.02
    Basic EPS, GAAP
    -0.27
    -0.15
    0.03
    -0.07
    - -
    -0.11
    -0.06
    Free Cash Flow per Basic Share
    - -
    -0.06
    -0.1
    -0.17
    - -
    -0.07
    -0.06
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    -0.44
    -0.59
    -0.56
    -0.58
    - -
    -0.38
    -0.41
    Tangible Book Value per Share
    0.22
    0.09
    0.1
    0.69
    - -
    1.32
    1.24
    Basic Weighted Avg Shares
    7
    7
    7
    8
    - -
    22
    24
    Sales/Revenue/Turnover
    - -
    - -
    1
    - -
    - -
    - -
    - -
    Operating Margin (%)
    -2,126,653.95
    -10,154.55
    42.86
    -213.76
    -887.98
    -2,081.99
    -355.54
    Depreciation Expense
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Net Income, GAAP
    -2
    -1
    - -
    -1
    -1
    -2
    -1
    Effective Tax Rate (%)
    - -
    - -
    1.05
    - -
    - -
    - -
    - -
    Profit Margin (%)
    -2,544,056.58
    -9,981.82
    41.51
    -215.23
    -897.69
    -2,094.59
    -358.75
    Working Capital
    2
    1
    1
    5
    4
    2
    2
    LT Debt
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Total Equity
    2
    1
    2
    7
    6
    30
    30
    Return on Invested Capital (%)
    - -
    - -
    19.75
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    -5.32
    - -
    - -
    - -
    - -
    Return on Common Equity (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -

    Capital Structure

    EUR

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Working Capital

    EUR

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Growth Rates

    EUR

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    176.44%
    2.68%
    Free Cash Flow
    - -
    36.5%
    3.96%
    Net Income, GAAP
    - -
    -65.47%
    -40.83%
    Sales/Revenue/Turnover
    - -
    977.82%
    245.44%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    EUR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    EUR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    -0.11
    2024
    - -
    - -
    - -
    - -
    -0.06

    Quarterly Dividends Per Share

    EUR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2022
    - -
    - -
    - -
    - -
    - -
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -

    Company Description

    Address
    Similar Companies
    Business